CurveBeam AI (ASX:CVB) Ltd MD Greg Brown tells Proactive the company combines point-of-care diagnostic cone beam CT imaging solutions with artificial intelligence (AI) and deep learning AI (DLAI) expertise to deliver solutions across orthopedics and bone health. It’s set to list tomorrow on the ASX following a $25 million IPO which was heavily supported by institutional investors. Brown says following on from the listing a priority will be to support operations in America where the company has a distribution deal with US-listed Stryker’s Foot & Ankle business.
CurveBeam AI to list on ASX with its clever imaging technology
